[1] 中国抗癌协会临床肿瘤学协作专业委员会.肿瘤化疗所致血小板减少症诊疗中国专家共识(2014版)[J].中华肿瘤杂志,2014,36(11):876-879.
[2] 王妍,马怀幸,刘天舒,等.重组人血小板生成素治疗肿瘤化疗所致血小板减少症的荟萃分析[J].循证医学,2013,13(4):225-229.
[3] 生媛,胡伟,魏红霞,等.574例血小板减少标本人工复检结果分析[J].东南大学学报:医学版,2012,31(2):205-207.
[4] 郑永威,袁榴娣.肝素诱导性血小板减少症的研究进展[J].东南大学学报:医学版,2014,33(6):815-819.
[5] OSEI-BIMPONG A.The effect of storage on the clinical utility of the immature platelet fraction[J].Hematology,2009,14(2):118-121.
[6] 田英,庞洁.网织血小板检测在肿瘤放化疗中的应用[J].国际检验医学杂志,2011,32(2):250-251.
[7] CHAOUI D,CHAKROUN T,ROBERT F,et al.Reticulated platelets:a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy[J].Transfusion,2005,45(5):766-772.
[8] PARCO S,VASCOTTO F.Application of reticulated platelets to transfusion management during autologous stem cell transplantation[J].Onco Targets Ther,2012,5:1-5.
[9] MARTINELLI G,MERLO P,FANTASIA R,et al.Reticulated platelet monitoring after autologous peripheral haematopoietic progenitor cell transplantation[J].Transfus Apher Sci,2009,40(3):175-181.
[10] 江虹,吕瑞雪,曾婷婷,等.应用血细胞分析仪检测网织血小板比率在肿瘤患者化疗中的临床应用[J].中华检验医学杂志,2009,32(2):184-186.
[11] VINHOLT P J,ALNOR A,NYBO M,et al.Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia[J].Platelets,2016,30:1-8.
[12] MIYAZAKI K,KOIKE Y,KUNISHIMA S,et al.Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia[J].Hematology,2015,20(10):587-592. |